Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: sub-analysis of the EXPAND study

The EXPAND Study demonstrated the effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation (NVAF) in routine clinical practice in Japan. This sub-analysis was conducted to reveal the effectiveness and safety of rivaroxaban in Japanese NVAF patients according to basel...

Descripción completa

Detalles Bibliográficos
Autores principales: Atarashi, Hirotsugu, Uchiyama, Shinichiro, Inoue, Hiroshi, Kitazono, Takanari, Yamashita, Takeshi, Shimizu, Wataru, Ikeda, Takanori, Kamouchi, Masahiro, Kaikita, Koichi, Fukuda, Koji, Origasa, Hideki, Shimokawa, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332581/
https://www.ncbi.nlm.nih.gov/pubmed/33728513
http://dx.doi.org/10.1007/s00380-021-01810-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332581/
https://www.ncbi.nlm.nih.gov/pubmed/33728513
http://dx.doi.org/10.1007/s00380-021-01810-5

Ejemplares similares